A Structured Exercise Program for Patients with Advanced Non-small Cell Lung Cancer

被引:139
|
作者
Temel, Jennifer S. [1 ]
Greer, Joseph A. [1 ]
Goldberg, Sarah [1 ]
Vogel, Paula Downes [1 ]
Sullivan, Michael [1 ]
Pirl, William F. [1 ]
Lynch, Thomas J. [1 ]
Christiani, David C. [1 ]
Smith, Matthew R. [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
关键词
Non-small cell lung cancer; Exercise; Supportive care; QUALITY-OF-LIFE; HIGH-DOSE CHEMOTHERAPY; PHYSICAL-ACTIVITY; BREAST-CANCER; FUNCTIONAL ASSESSMENT; MEGESTROL-ACETATE; AEROBIC EXERCISE; OUTPATIENT REHABILITATION; PULMONARY REHABILITATION; RESISTANCE EXERCISE;
D O I
10.1097/JTO.0b013e31819d18e5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Exercise improves functional outcome and symptoms for certain cancer populations, but the feasibility, efficacy, and safety of structured exercise in patients with lung cancer is unknown. In this Study, we examined the feasibility of a hospital-based exercise program for patients with advanced non-small cell lung cancer. Methods: This study included patients with newly diagnosed advanced stage non-small cell lung cancer and Eastern Cooperative Oncology Group performance status 0-1. A physical therapist facilitated twice-weekly sessions of aerobic exercise and weight training over an 8-week period. The primary end point was feasibility of the intervention, defined as adherence to the exercise program. Secondary endpoints included functional capacity, measured by the 6-minute walk test and Muscle strength, as well as quality Of life, lung cancer symptoms and fatigue, measured by the Functional Assessment of Cancer Therapy-lung and Functional Assessment of Cancer Therapy-fatigue scales. Results: Between October 2004 and August 2007, 25 patients enrolled in the study. All participants received anticancer therapy during the Study period. Twenty patients (80%) underwent the baseline physical therapy evaluation. Eleven patients (44%) completed all 16 sessions. An additional 6 patients attended at least 6 sessions (range, 6-15), and 2 patients only attended one session. Study completers experienced a significant reduction in lung cancer symptoms and no deterioration in their 6-minute walk test or muscle strength. Conclusions: Although the majority of participants attempted the exercise program, less than half were able to complete the intervention. Those who completed the program experienced an improvement in their lung cancer symptoms. Community-based or briefer exercise interventions may be more feasible in this population.
引用
收藏
页码:595 / 601
页数:7
相关论文
共 50 条
  • [41] Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer
    Kimura, Madoka
    Naito, Tateaki
    Kenmotsu, Hirotsugu
    Taira, Tetsuhiko
    Wakuda, Kazushige
    Oyakawa, Takuya
    Hisamatsu, Yasushi
    Tokito, Takaaki
    Imai, Hisao
    Akamatsu, Hiroaki
    Ono, Akira
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Mori, Keita
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    SUPPORTIVE CARE IN CANCER, 2015, 23 (06) : 1699 - 1708
  • [42] Pharmacokinetics of Cemiplimab in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Papachristos, A.
    Masinde, S.
    Davis, J. D.
    Gullo, G.
    Rietschel, P.
    Paccaly, A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S308 - S309
  • [43] Chemotherapy Utilization In Advanced Non-Small Cell Lung Cancer Patients With Depression
    Sullivan, D. R.
    Duckart, J. P.
    Slatore, C. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [44] Management of patients with advanced non-small cell lung cancer: role of gefitinib
    Velcheti, Vamsidhar
    Morgensztern, Daniel
    Govindan, Ramaswamy
    BIOLOGICS-TARGETS & THERAPY, 2010, 4 : 83 - 90
  • [45] Gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer
    Park, SH
    Jeong, SH
    Kyung, SY
    Lim, YH
    An, CH
    Lee, SP
    Park, JW
    Bang, SM
    Cho, EK
    Shin, DB
    Lee, JH
    MEDICAL ONCOLOGY, 2005, 22 (04) : 359 - 366
  • [46] Treatment of older patients with advanced non-small cell lung cancer: A challenge
    Decoster, Lore
    Schallier, Denis
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (04) : 528 - 533
  • [47] Circadian function in patients with advanced non-small cell lung cancer.
    Levin, Robert D.
    Lis, Christopher G.
    Peterson, Caryn
    Grutsch, James F.
    Hrushesky, William Jm
    Quiton, Jovelyn
    Quinn, Kathleen
    Daehler, Maryann
    Gupta, Digant
    CANCER RESEARCH, 2006, 66 (08)
  • [48] Update on gemcitabine/carboplatin in patients with advanced non-small cell lung cancer
    Harper, P
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 2 - 12
  • [49] Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer
    Shepherd, FA
    Abratt, RP
    Anderson, H
    Gatzemeier, U
    Anglin, G
    Iglesias, J
    SEMINARS IN ONCOLOGY, 1997, 24 (02) : S50 - S55
  • [50] Immunotherapy Beyond Progression for Patients with Advanced Non-Small Cell Lung Cancer
    Ge, X.
    Zhang, Z.
    Yan, X.
    Zhang, F.
    Yuan, F.
    Han, X.
    Huang, Z.
    Ma, J.
    Wang, L.
    Tao, H.
    Li, X.
    Zhang, S.
    Zhi, X.
    Hu, Y.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S641 - S642